As of June 09, 2026, the three largest insider holders of OLMA are Biocapital Advisors Lp Paradigm (TenPercentOwner, 5.50Mn shares), Capital Life Sciences Investors, Llc Bain (TenPercentOwner, 4.30Mn shares), Cyrus Harmon (Chief Technology Officer, 727.77K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Partners L P/Il Bvf | - | 347,970 | 0 | 14 Jan, 2025 |
| Andrew Rappaport | - | 0 | 385,965 | 06 Mar, 2024 |
| Shane William Charles Kovacs | Ch. Operating Financial Off. | 139,727 | 0 | 15 Jan, 2026 |
| Capital Life Sciences Investors, Llc Bain | - | 0 | 4,300,000 | 13 Jan, 2025 |
| Shawnte Mitchell | Chief Legal Officer | 233 | 0 | 05 Mar, 2026 |
| G. Walmsley Graham | - | 0 | 700,761 | 18 Dec, 2024 |
| Kinney Horn | Chief Business Officer | 2,458 | 0 | 14 Mar, 2022 |
| David C. Myles | Ch. Discov. Non Clin Dev Off | 542,761 | 144,846 | 14 Jan, 2026 |
| Sean Bohen | President And Ceo | 237,650 | 0 | 29 Dec, 2025 |
| Cyrus Harmon | Chief Technology Officer | 727,770 | 0 | 21 Jan, 2026 |
| Biocapital Advisors Lp Paradigm | - | 0 | 5,503,600 | 05 Aug, 2024 |
| Naseem Zojwalla | Chief Medical Officer | 4,488 | 0 | 23 Dec, 2025 |
| Sasha Lu Austin | Vp Of Finance And Controller | 16,188 | 0 | 17 Feb, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 03 Mar, 2026 | Shawnte Mitchell | Common Stock | A | 15,000 | $4.37 | 15,000 | D | M |
| 03 Mar, 2026 | Shawnte Mitchell | Common Stock | D | 15,000 | $23.01 | 0 | D | S |
| 04 Mar, 2026 | Shawnte Mitchell | Common Stock | A | 25,000 | $4.37 | 25,000 | D | M |
| 04 Mar, 2026 | Shawnte Mitchell | Common Stock | D | 24,767 | $24.25 | 233 | D | S |
| 04 Mar, 2026 | Shawnte Mitchell | Comon Stock | D | 233 | $24.69 | 0 | D | S |
| 03 Mar, 2026 | Shawnte Mitchell | Stock Option (Right to Buy) | D | 15,000 | $0.00 | 435,000 | D | M |
| 04 Mar, 2026 | Shawnte Mitchell | Stock Option (Right to Buy) | D | 25,000 | $0.00 | 410,000 | D | M |
| 02 Feb, 2026 | Sasha Lu Austin | Common Stock | A | 11,700 | $0.00 | 16,188 | D | A |
| 02 Feb, 2026 | Sasha Lu Austin | Stock Option (Right to Buy) | A | 29,250 | $0.00 | 29,250 | D | A |
| 02 Feb, 2026 | Sean Bohen | Stock Option (Right to Buy) | A | 850,000 | $0.00 | 850,000 | D | A |
| 02 Feb, 2026 | Naseem Zojwalla | Stock Option (Right to Buy) | A | 250,000 | $0.00 | 250,000 | D | A |
| 02 Feb, 2026 | Shawnte Mitchell | Stock Option (Right to Buy) | A | 220,000 | $0.00 | 220,000 | D | A |
| 02 Feb, 2026 | Naseem Zojwalla | Stock Option (Right to Buy) | A | 250,000 | $0.00 | 250,000 | D | A |
| 02 Feb, 2026 | David C. Myles | Stock Option (Right to Buy) | A | 250,000 | $0.00 | 250,000 | D | A |
| 02 Feb, 2026 | Naseem Zojwalla | Performance Stock Options (Right to Buy) | A | 106,250 | $0.00 | 106,250 | D | A |
| 02 Feb, 2026 | Sean Bohen | Performance Stock Options (Right to Buy) | A | 275,000 | $0.00 | 275,000 | D | A |
| 02 Feb, 2026 | Shawnte Mitchell | Performance Stock Options (Right to Buy) | A | 56,250 | $0.00 | 56,250 | D | A |
| 02 Feb, 2026 | Naseem Zojwalla | Performance Stock Options (Right to Buy) | A | 106,250 | $0.00 | 106,250 | D | A |
| 02 Feb, 2026 | David C. Myles | Performance Stock Options (Right to Buy) | A | 106,250 | $0.00 | 106,250 | D | A |
| 20 Jan, 2026 | Cyrus Harmon | Common Stock | D | 10,000 | $26.88 | 727,770 | D | S |